Immagene Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $21.8M

  • Investors
  • 10

Immagene General Information

Description

Operator of a biotech platform intended to develop precision immuno-oncology treatments. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and is building a pipeline of Immunotherapies, enabling researchers to focus on the advancement of novel drugs in areas of unmet medical needs.

Contact Information

Website
www.immagene.nl
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kloosterstraat 9
  • RK 1215
  • 5349 AB Oss
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Kloosterstraat 9
  • RK 1215
  • 5349 AB Oss
  • Netherlands

Immagene Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immagene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 28-Mar-2024 $21.8M Completed Pre-Clinical Trials
2. Seed Round 01-Nov-2021 Completed Pre-Clinical Trials
1. Seed Round 01-Sep-2020 Completed Startup
To view Immagene’s complete valuation and funding history, request access »

Immagene Patents

Immagene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202319887-D0 Compounds Pending 22-Dec-2023

Immagene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immagene Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Flanders Future Techfund Venture Capital Minority
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority
Qbic Fund Venture Capital Minority
V-Bio Ventures Venture Capital Minority
VIB Not-For-Profit Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Immagene FAQs

  • When was Immagene founded?

    Immagene was founded in 2020.

  • Where is Immagene headquartered?

    Immagene is headquartered in Oss, Netherlands.

  • What is the size of Immagene?

    Immagene has 7 total employees.

  • What industry is Immagene in?

    Immagene’s primary industry is Drug Discovery.

  • Is Immagene a private or public company?

    Immagene is a Private company.

  • What is Immagene’s current revenue?

    The current revenue for Immagene is .

  • How much funding has Immagene raised over time?

    Immagene has raised $21.8M.

  • Who are Immagene’s investors?

    Flanders Future Techfund, Johnson & Johnson Innovation - JJDC, Qbic Fund, V-Bio Ventures, and VIB are 5 of 10 investors who have invested in Immagene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »